Hansson O - Search Results

1

Clinical performance and robustness evaluation of plasma amyloid-β_42/40 prescreening.

Rabe C, Bittner T, Jethwa A, Suridjan I, Manuilova E, Friesenhahn M, Stomrud E, Zetterberg H, Blennow K, Hansson O; Alzheimer's Disease Neuroimaging Initiative† and the Swedish BioFINDER study. Rabe C, et al. Among authors: hansson o. Alzheimers Dement. 2023 Apr;19(4):1393-1402. doi: 10.1002/alz.12801. Epub 2022 Sep 23. Alzheimers Dement. 2023. PMID: 36150024

2

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.

Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Hansson O, et al. Lancet Neurol. 2006 Mar;5(3):228-34. doi: 10.1016/S1474-4422(06)70355-6. Lancet Neurol. 2006. PMID: 16488378

3

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.

Hansson O, Zetterberg H, Buchhave P, Andreasson U, Londos E, Minthon L, Blennow K. Hansson O, et al. Dement Geriatr Cogn Disord. 2007;23(5):316-20. doi: 10.1159/000100926. Epub 2007 Mar 19. Dement Geriatr Cogn Disord. 2007. PMID: 17374949

4

Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease.

Andersson ME, Sjölander A, Andreasen N, Minthon L, Hansson O, Bogdanovic N, Jern C, Jood K, Wallin A, Blennow K, Zetterberg H. Andersson ME, et al. Among authors: hansson o. Int J Mol Med. 2007 Aug;20(2):233-9. Int J Mol Med. 2007. PMID: 17611642

5

Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly.

Stomrud E, Hansson O, Blennow K, Minthon L, Londos E. Stomrud E, et al. Among authors: hansson o. Dement Geriatr Cogn Disord. 2007;24(2):118-24. doi: 10.1159/000105017. Epub 2007 Jul 2. Dement Geriatr Cogn Disord. 2007. PMID: 17622715

6

Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.

Hansson O, Buchhave P, Zetterberg H, Blennow K, Minthon L, Warkentin S. Hansson O, et al. Neurobiol Aging. 2009 Feb;30(2):165-73. doi: 10.1016/j.neurobiolaging.2007.06.009. Epub 2007 Jul 23. Neurobiol Aging. 2009. PMID: 17646035

7

CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies.

Boström F, Hansson O, Gerhardsson L, Lundh T, Minthon L, Stomrud E, Zetterberg H, Londos E. Boström F, et al. Among authors: hansson o. Neurobiol Aging. 2009 Aug;30(8):1265-71. doi: 10.1016/j.neurobiolaging.2007.10.018. Epub 2008 Jan 8. Neurobiol Aging. 2009. PMID: 18191875

8

Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.

Höglund K, Hansson O, Buchhave P, Zetterberg H, Lewczuk P, Londos E, Blennow K, Minthon L, Wiltfang J. Höglund K, et al. Among authors: hansson o. Neurodegener Dis. 2008;5(5):268-76. doi: 10.1159/000119457. Epub 2008 Feb 29. Neurodegener Dis. 2008. PMID: 18309230

9

Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years.

Stomrud E, Hansson O, Minthon L, Blennow K, Rosén I, Londos E. Stomrud E, et al. Among authors: hansson o. Neurobiol Aging. 2010 Feb;31(2):215-23. doi: 10.1016/j.neurobiolaging.2008.03.025. Neurobiol Aging. 2010. PMID: 18462837

10

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.

Hansson O, Zetterberg H, Vanmechelen E, Vanderstichele H, Andreasson U, Londos E, Wallin A, Minthon L, Blennow K. Hansson O, et al. Neurobiol Aging. 2010 Mar;31(3):357-67. doi: 10.1016/j.neurobiolaging.2008.03.027. Epub 2008 May 19. Neurobiol Aging. 2010. PMID: 18486992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

771 results

Search Page